Archive for June, 2014
So what is next for tax inversions and when?
As an international tax advisor we are always interested when the topic of “tax inversion” hits the headlines as was recently the case with the announcement of the Medtronic for Covidien, Pfizer for AstraZenca, Questcor for Mallinckrot, and Horizon Pharma for Vidara Therapeutics deals. A tax inversion is generally a transaction where a foreign corporation […]
Connect With Us